Mahon Paul A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Mar 19, 2026
- Accession no.
- 0001231589-26-000008
- Filed
- Mar 19, 2026
- Trade date
- Mar 19, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.40M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahon Paul ACIK 0001231589 | Officer (EVP & GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | Common Stock | MOption exerciseAcquired | +8,300 | $146.03 | +$1,212,049 | 53,472 | Direct | |
| Mar 19, 2026 | Common Stock | SSaleDisposed | −753 | $527.47F2 | −$397,184.91 | 52,719 | Direct | |
| Mar 19, 2026 | Common Stock | SSaleDisposed | −1,439 | $528.41F3 | −$760,381.99 | 51,280 | Direct | |
| Mar 19, 2026 | Common Stock | SSaleDisposed | −2,808 | $529.82F4 | −$1,487,734.56 | 48,472 | Direct | |
| Mar 19, 2026 | Common Stock | SSaleDisposed | −1,776 | $530.63F5 | −$942,398.88 | 46,696 | Direct | |
| Mar 19, 2026 | Common Stock | SSaleDisposed | −794 | $531.62F6 | −$422,106.28 | 45,902 | Direct | |
| Mar 19, 2026 | Common Stock | SSaleDisposed | −650 | $532.50F7 | −$346,125 | 45,252 | Direct | |
| Mar 19, 2026 | Common Stock | SSaleDisposed | −80 | $533.41F8 | −$42,672.8 | 45,172 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | Common Stock | MOption exerciseDisposed | −8,300 | $0.00 | $0 | 25,200 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $526.99 to $527.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $528.035 to $529.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $529.10 to $530.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $530.11 to $531.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $531.17 to $532.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $532.19 to $532.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $533.34 to $533.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.